Gerwin D Rodenburg

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. pmc Prevalence and clinical course in invasive infections with meningococcal endotoxin variants
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
    PLoS ONE 7:e49295. 2012
  2. doi request reprint Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
    J Pediatr 159:965-70.e1. 2011
  3. pmc Hospitalization due to varicella in the Netherlands
    Alies van Lier
    Department of Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, RIVM, Postbox 1, 3720 BA Bilthoven, The Netherlands
    BMC Infect Dis 11:85. 2011
  4. doi request reprint Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, The Netherlands
    Vaccine 28:1391-6. 2010
  5. pmc Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands
    Gerwin D Rodenburg
    Wilhelmina Children s Hospital University Medical Center, Utrecht, The Netherlands
    Emerg Infect Dis 16:816-23. 2010
  6. doi request reprint Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains
    Elske J M van Gils
    University Medical Center Utrecht, Wilhelmina Children s Hospital, Department of Pediatric Immunology and Infectious Diseases, 3508 AB Utrecht, The Netherlands
    JAMA 304:1099-106. 2010
  7. doi request reprint Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits
    Angelique G S C Jansen
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, UMC Utrecht, The Netherlands
    Vaccine 27:2394-401. 2009
  8. doi request reprint Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial
    Elske J M van Gils
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, PO Box 85090, 3508 AB Utrecht, The Netherlands
    JAMA 302:159-67. 2009
  9. pmc Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial
    Elske J M van Gils
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
    PLoS ONE 6:e20229. 2011
  10. doi request reprint Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome
    Angelique G S C Jansen
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
    Clin Infect Dis 49:e23-9. 2009

Collaborators

Detail Information

Publications13

  1. pmc Prevalence and clinical course in invasive infections with meningococcal endotoxin variants
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
    PLoS ONE 7:e49295. 2012
    ..Meningococcal strains with such lipid A endotoxin variants have been found previously in adult meningitis patients, where they caused less blood coagulopathy because of decreased TLR4 activation...
  2. doi request reprint Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
    J Pediatr 159:965-70.e1. 2011
    ..To determine whether nasopharyngeal pneumococcal carriage with serotypes 6B, 19F, or 23F interferes with immunoglobulin G (IgG) antibody responses to vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) at the age 24 months...
  3. pmc Hospitalization due to varicella in the Netherlands
    Alies van Lier
    Department of Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, RIVM, Postbox 1, 3720 BA Bilthoven, The Netherlands
    BMC Infect Dis 11:85. 2011
    ..Better knowledge about the severity of varicella among Dutch hospitalized patients is needed. Therefore, a medical record research was conducted among hospitalized patients with diagnosis varicella...
  4. doi request reprint Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, The Netherlands
    Vaccine 28:1391-6. 2010
    ..0 microg/ml and >or=5.0 microg/ml) and 19F (>or=5.0 microg/ml). Surveillance studies are warranted for vaccine impact on 6B and 19F disease cases after reduced-dose PCV-7 schedules...
  5. pmc Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands
    Gerwin D Rodenburg
    Wilhelmina Children s Hospital University Medical Center, Utrecht, The Netherlands
    Emerg Infect Dis 16:816-23. 2010
    ..IPD rates did not change for other age groups. In the Netherlands, PCV-7 offered high protection against vaccine-serotype IPD in vaccinated children, but increases of non-vaccine-serotype IPD reduced net vaccine benefits...
  6. doi request reprint Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains
    Elske J M van Gils
    University Medical Center Utrecht, Wilhelmina Children s Hospital, Department of Pediatric Immunology and Infectious Diseases, 3508 AB Utrecht, The Netherlands
    JAMA 304:1099-106. 2010
    ..Because spontaneous fluctuations in time and antibiotic selective pressure may have induced this serotype 19A increase, controlled studies are needed to assess the role of PCV-7...
  7. doi request reprint Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits
    Angelique G S C Jansen
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, UMC Utrecht, The Netherlands
    Vaccine 27:2394-401. 2009
    ..Beyond the age of 4yrs, 19% of IPD patients were immunocompromised, and this considerable percentage may have implications for vaccine efficacy...
  8. doi request reprint Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial
    Elske J M van Gils
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, PO Box 85090, 3508 AB Utrecht, The Netherlands
    JAMA 302:159-67. 2009
    ..The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on pneumococcal carriage in children are largely unknown, although highly relevant in the context of subsequent herd effects...
  9. pmc Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial
    Elske J M van Gils
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
    PLoS ONE 6:e20229. 2011
    ..Because of the reported negative association of vaccine serotype pneumococci and Staphylococcus aureus in the nasopharynx, we explored the effect of PCV7 on nasopharyngeal colonisation with S. aureus in children and parents...
  10. doi request reprint Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome
    Angelique G S C Jansen
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
    Clin Infect Dis 49:e23-9. 2009
    ..The Streptococcus pneumoniae polysaccharide capsule may be related to invasive pneumococcal disease (IPD) course...
  11. pmc Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life
    Gerwin D Rodenburg
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
    PLoS ONE 7:e46916. 2012
    ..Data on PCV7-induced mucosal antibodies in relation to systemic or natural anticapsular antibodies are scarce...
  12. doi request reprint Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial
    Elske J M van Gils
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center, Utrecht, The Netherlands
    Vaccine 29:7595-8. 2011
    ..influenzae and 68% for M. catarrhalis at the age of 18 months. Reduced dose (CRM197) schedules induced a slight reduction in overall pneumococcal carriage but no increases in the presence of H. influenzae and M. catarrhalis...
  13. doi request reprint Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008
    Karen van Wessel
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
    Clin Infect Dis 53:e1-7. 2011
    ..The epidemiology, the course of disease, and the outcome of ntHi invasive disease are not well established. For prevention, risk groups that might benefit from vaccination have to be defined...